as Teva Pharmaceuticals learned in 2016 after its much-lauded acquisition of Allergan’s generic business, Actavis Generics. In its acquisition of the firm, Teva’s dealmakers coupled two leading ...

Teva’s $40.5 billion acquisition of Allergan’s generics business, formerly known as Actavis, has gone ahead as planned – and the generics mega-merger is set to impact the UK. In order to ...

Not content with buying up a big chunk of the world’s generics market with its $40.5 billion merger with Actavis, Teva is muscling in on biosimilars with a deal with South Korea’s Celltrion.

Learn about Actavis Pharma Development Centre Pvt. Ltd in Bengaluru, Karnataka.Find comprehensive contact details, including phone numbers and email addresses, and get directions to the location.